Jefferies Financial Group upgraded shares of Sandoz Group (OTCMKTS:SDZNY – Free Report) from a hold rating to a strong-buy rating in a research report report published on Thursday morning,Zacks.com reports.
Sandoz Group Price Performance
SDZNY opened at $85.73 on Thursday. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.29 and a quick ratio of 0.82. Sandoz Group has a 12 month low of $35.61 and a 12 month high of $86.80. The stock has a fifty day moving average price of $76.52 and a 200-day moving average price of $67.55.
About Sandoz Group
Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.
The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.
Recommended Stories
- Five stocks we like better than Sandoz Group
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
